Crysvita 10mg (Burosumab-Twza Vials) 10mg/ml x 1ml

Crysvita 10mg (Burosumab-Twza) is an injectable treatment in 10mg/ml vials used for managing specific metabolic bone conditions. Store between 2-8°C and protect from light. Always follow healthcare provider guidance for use.

Strength

10mg/ml x 1ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Kyowa Kirin

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Crysvita 10mg is used to treat conditions related to excess phosphate in the blood, such as X-linked hypophosphatemia (XLH). It helps regulate phosphate levels by increasing absorption in the kidneys. This medication is typically prescribed when dietary changes and supplements are insufficient. Always consult a healthcare professional for personalized advice.

Side Effects

After administration, Crysvita 10mg works gradually to balance phosphate levels in the body. Users may notice improved bone strength and reduced symptoms over time. Individual responses vary, and effects depend on consistent use and medical supervision. Keep track of any changes and report concerns to a healthcare provider.

Precautions & Warnings

Store Crysvita 10mg vials refrigerated between 2-8°C and avoid freezing. Protect from light by keeping vials in their original packaging. Do not use if the solution is discolored or contains particles. Always handle with clean hands and follow aseptic techniques during preparation and injection.

Avoid Interactions

Crysvita 10mg may interact with phosphate supplements or vitamin D analogs, potentially leading to elevated phosphate levels. Inform your healthcare provider about all medications, including over-the-counter products and supplements. Alcohol and certain antibiotics may also affect how the body processes this medication.

References

Frequently Asked Questions

Crysvita 10mg is used to treat conditions like X-linked hypophosphatemia (XLH) by helping regulate phosphate levels in the blood.

Store Crysvita 10mg vials refrigerated between 2-8°C and protect from light. Do not freeze.

Crysvita 10mg is available through prescription; consult a healthcare provider for valid online pharmacies.

Common effects may include injection site reactions, headache, or tooth pain. Report persistent issues to a healthcare professional.

Safety during pregnancy has not been established; discuss risks and benefits with a healthcare provider before use.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.